The syndrome can be defined as a cluster of abnormalities, including obesity, hypertension, dyslipidemia and type 2 diabetes, that are associated with insulin resistance and compensatory hyperinsulinemia. However, a cause-and-effect relationship between insulin resistance, these diseases and the mechanisms through which insulin resistance influences their development has yet to be proven, well defined or well explained.